Abstract
Background and aimsThere have been advancements in artificial intelligence (AI) and deep learning in the past decade. Recently, OpenAI Inc. has launched a new chatbot, called ChatGPT that interacts in a conversational way and its dialogue format makes is user friendly and fast. In this paper we aimed to explore the current position and the accuracy of currently available version of ChatGPT in relation to healthcare and medical research. MethodsWe searched the PubMed, Scopus, and Google databases from 15th to 25th February 2023, using the keywords: ‘ChatGPT’ AND ‘medical research, healthcare, and scientific writing’. We found 29 results in PubMed and 9 results in Scopus database., in English language. In addition, we (RV, AM) interacted with ChatGPT multiple times to review accuracy of responses of various medical questions. ResultsUsing literature search and interactions with ChatGPT with medical questions, we infer that this version generates answers rapidly but narrates data from existing internet literature in a general manner. However, as emphasised by the company in the landing page of ChatGPT, we found errors in responses to medical questions, Further, narrated data were limited up to September 2021. Positive features include admission of its limitations in medical field, and as it has been designed, learning from previous answers. ConclusionCurrent version of ChatGPT may be useful in a limited manner as a narrative AI chatbot for medical personnel, however, researchers are advised to fact check all statements provided, keeping in mind its limitations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.